Veracyte
VCYT
232 hedge funds and large institutions have $1.96B invested in Veracyte in 2023 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 91 increasing their positions, 82 reducing their positions, and 24 closing their positions.
200% more funds holding in top 10
Funds holding in top 10: 1 → 3 (+2)
13% more capital invested
Capital invested by funds: $1.74B → $1.96B (+$222M)
11% more repeat investments, than reductions
Existing positions increased: 91 | Existing positions reduced: 82
4% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 24
0% more funds holding
Funds holding: 232 → 232 (0)
2.64% less ownership
Funds ownership: 109.06% → 106.42% (-2.6%)
58% less call options, than puts
Call options by funds: $252K | Put options by funds: $593K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$27.1M |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
+$12.2M |
| 3 |
BlackRock
New York
|
+$6.63M |
| 4 |
OAM
Oberweis Asset Management
Lisle,
Illinois
|
+$6.55M |
| 5 |
Morgan Stanley
New York
|
+$6.01M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$22.7M |
| 2 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
-$14.1M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$13.6M |
| 4 |
State Street
Boston,
Massachusetts
|
-$13.6M |
| 5 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$13.4M |
VCYT Hedge Fund Activity: Q2 2023 in Review
232 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Veracyte (VCYT) for Q2 2023, worth a combined $1.96B — up 13% from $1.74B a quarter earlier.
Buyers outnumbered sellers: 25 funds opened new VCYT positions and 24 closed out — a net gain of 1 holder — while 91 added to existing stakes and 82 trimmed.
The largest buyer was Point72 Asset Management, opening a new position worth an estimated $27.1M. The largest seller was Citadel Advisors, cutting an estimated $22.7M.
- 232 institutional investors held Veracyte (VCYT) as of Q2 2023, unchanged from Q1 2023.
- Funds reported $1.96B of Veracyte stock for Q2 2023, up 13% quarter-over-quarter.
- 25 funds opened new Veracyte positions in Q2 2023 and 24 closed out, a net change of +1 holder.
- The largest Veracyte buyer in Q2 2023 was Point72 Asset Management, an estimated $27.1M added.
- The largest Veracyte seller in Q2 2023 was Citadel Advisors, an estimated $22.7M sold.
Based on aggregated 13F filings for Q2 2023.